Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses R Kamya

Showing results (141-150 of 546) with videos related to

Pageof 55
Sort By:
The Lancet. Global Health|December 1, 2014
Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trialJaco Homsy, Grant Dorsey, Emmanuel Arinaitwe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2014
Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trialJoaniter I Nankabirwa, Bonnie Wandera, Pauline Amuge, et al.
Antimicrobial Agents and Chemotherapy|June 11, 2014
Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquineAlice C Eziefula, Helmi Pett, Lynn Grignard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 5, 2010
Breastfeeding and the risk of malaria in children born to HIV-infected and uninfected mothers in rural UgandaNeil Vora, Jaco Homsy, Abel Kakuru, et al.
BMJ (Clinical Research Ed.)|July 23, 2009
Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trialJane Achan, James K Tibenderana, Daniel Kyabayinze, et al.
Research Square|February 20, 2025
Relating household entomological measures to individual malaria riskMax McClure, Emmanuel Arinaitwe, Moses R Kamya, et al.
AIDS Care|August 6, 2013
Acceptability and feasibility of serial HIV antibody testing during pregnancy/postpartum and male partner testing in Tororo, UgandaLena H Kim, Emmanuel Arinaitwe, Bridget Nzarubara, et al.
East African Journal of Applied Health Monitoring and Evaluation|August 21, 2020
Closing the gap: A novel metric of change in performanceRichard Katuramu, Jeanna Wallenta, Fred C Semitala, et al.
Clinical Immunology (Orlando, Fla.)|March 24, 2009
Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan childrenTheodore Ruel, Isaac Ssewanyana, Jane Achan, et al.
The Lancet. Global Health|November 2, 2020
Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled dataSilke Fernandes, Vincent Were, Julie Gutman, et al.
Pageof 55

Showing results (141-150 of 546) with videos related to

Sort By:
Pageof 55
The Lancet. Global Health|December 1, 2014
Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trialJaco Homsy, Grant Dorsey, Emmanuel Arinaitwe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2014
Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trialJoaniter I Nankabirwa, Bonnie Wandera, Pauline Amuge, et al.
Antimicrobial Agents and Chemotherapy|June 11, 2014
Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquineAlice C Eziefula, Helmi Pett, Lynn Grignard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 5, 2010
Breastfeeding and the risk of malaria in children born to HIV-infected and uninfected mothers in rural UgandaNeil Vora, Jaco Homsy, Abel Kakuru, et al.
BMJ (Clinical Research Ed.)|July 23, 2009
Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trialJane Achan, James K Tibenderana, Daniel Kyabayinze, et al.
Research Square|February 20, 2025
Relating household entomological measures to individual malaria riskMax McClure, Emmanuel Arinaitwe, Moses R Kamya, et al.
AIDS Care|August 6, 2013
Acceptability and feasibility of serial HIV antibody testing during pregnancy/postpartum and male partner testing in Tororo, UgandaLena H Kim, Emmanuel Arinaitwe, Bridget Nzarubara, et al.
East African Journal of Applied Health Monitoring and Evaluation|August 21, 2020
Closing the gap: A novel metric of change in performanceRichard Katuramu, Jeanna Wallenta, Fred C Semitala, et al.
Clinical Immunology (Orlando, Fla.)|March 24, 2009
Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan childrenTheodore Ruel, Isaac Ssewanyana, Jane Achan, et al.
The Lancet. Global Health|November 2, 2020
Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled dataSilke Fernandes, Vincent Were, Julie Gutman, et al.
Pageof 55